SCHEMBL3983572

SCHEMBL3983572

CC(=O)C(N)c1ccc(-c2ccc(CNC3CCN(C(=O)O)CC3)cn2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
LTA4H P09960 1/20 0.36
HTR5A P47898 1/20 0.36
CDK7 P50613 1/20 0.36
CDK13 Q14004 1/20 0.36
CXCR4 P61073 1/20 0.36
TPH1 P17752 3/20 0.36
TP53 P04637 1/20 0.35
DRD4 P21917 1/20 0.35
TEAD1 P28347 1/20 0.35
CD274 Q9NZQ7 2/20 0.35
PDCD1 Q15116 1/20 0.35
C3AR1 Q16581 1/20 0.35
DPP4 P27487 1/20 0.35
DPP7 Q9UHL4 1/20 0.35
ADAM17 P78536 1/20 0.34
HPGDS O60760 1/20 0.34
NFKB1 P19838 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3983576 0.85 LTA4H (0.40) NPC1RAB9ASMN1; SMN2LTA4HHTR5A
SCHEMBL3984090 0.84 CXCR4 (0.42) NPC1RAB9ASMN1; SMN2CXCR4TP53
SCHEMBL3981387 0.82 GPR119 (0.44)
SCHEMBL3985778 0.81 NPC1 (0.42) NPC1RAB9ASMN1; SMN2HTR5ACXCR4
SCHEMBL3984556 0.77 KDM1A (0.47) CXCR4DRD4CD274PDCD1ADAM17
SCHEMBL3985988 0.74 KDM1A (0.48) CXCR4DRD4TEAD1CD274PDCD1
SCHEMBL5086233 0.72 GPR119 (0.52)
SCHEMBL4097506 0.72 GPR119 (0.57) TP53
SCHEMBL3984151 0.72 NPC1 (0.40) NPC1RAB9ASMN1; SMN2HTR5ACXCR4
SCHEMBL3982357 0.72 FYN (0.48) HPGDS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2059516-A1 PYRIDINE COMPOUNDS FOR TREATING GPR119 RELATED DISORDERS BIOVITRUM AB (publ) (SE) 2009-05-20 EP disclosed
WO-2008025798-A1 PYRIDINE COMPOUNDS FOR TREATING GPR119 RELATED DISORDERS BIOVITRUM AB (PUBL) (SE) 2008-03-06 WO disclosed